EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Implications of Thrombocytopenia in Chinese Patients With Newly Diagnosed Multiple Myeloma

Xiaojing Li iD, Xiaohui Lai, Xiaolin Wang, Qiang Liu, Xin Liu, Luqun Wang, Jun Peng, Ping Chen, Hai Zhou

Cancer Medicine · 2025

DOI: 10.1002/cam4.71353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Xiaojing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Thrombocytopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Taishan Scholar Foundation of Shandong Province, Joint Funds for the Innovation of Science and Technology, Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thrombocytopenia is less common but shows high risk of early mortality in newly diagnosed multiple myeloma (NDMM) patients. In the era of novel agents‐based induction therapy (NAIT), it is unclear whether NAIT can overcome the poor prognosis associated with thrombocytopenia.

Objectives

To evaluate the prognostic implications of thrombocytopenia in NDMM patients.

Methods

We retrospectively analyzed 1363 NDMM patients baseline characteristics, treatment response and survival, further performed regression analysis, constructed a nomogram model to predict progression free survival (PFS), and further internally validated this model.

Results

Overall, 211 (15.48%) NDMM patients were harboring thrombocytopenia, with advanced disease stages and worse outcomes. Their PFS (15 months vs 21.5 months, p < 0.001)and overall survival (47 months vs 77 months, p < 0.001) were significantly inferior compared with patients without thrombocytopenia. In NDMM receiving NAIT, the overall response (87.8% vs 92.4%, p = 0.33) but not deep response or survival could be improved between patients with and without thrombocytopenia. Five important variables (thrombocytopenia, R‐ISS stage III, NAIT, deep response and autologous stem‐cell transplantation) in multivariate Cox analysis were incorporated in the nomogram, which was further validated by internal datasets. The Calibration curve and time‐dependent Receiver operating characteristic showed that the model accurately predicted the 12‐ and 24‐ months PFS of NDMM patients.

Conclusions

Thrombocytopenia has an indispensable prognostic effect in decreasing responses to induction therapy and survival in NDMM patients. Thrombocytopenia might need to be regarded as an independent prognostic factor in risk stratification of Chinese NDMM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaThrombocytopeniaHumansMaleFemaleMiddle AgedRetrospective StudiesPrognosisAgedNomogramsAdultChinaAntineoplastic Combined Chemotherapy ProtocolsInduction ChemotherapyHematopoietic Stem Cell TransplantationEast Asian People

Stichwörter der Autor:innen

multiple myelomaprognosisthrombocytopenia

Autor:innen und Institutionen

  • Department of Hematology, Qilu Hospital of Shandong University, Jinan, China.
  • Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Shandong Provincial Key Laboratory of Immunohematology, Qilu Hospital of Shandong University, Jinan, China.
  • Shandong Provincial Clinical Medicine Research Center for Hematology, Qilu Hospital of Shandong University, Jinan, China.

ORCID-Profile: Xiaojing Li

Förderung

  • National Natural Science Foundation of China
  • Taishan Scholar Foundation of Shandong Province
  • Joint Funds for the Innovation of Science and Technology, Fujian Province

Zitieren

APA

Li, X., Lai, X., Wang, X., Liu, Q., Liu, X., Wang, L., Peng, J., Chen, P., & Zhou, H. (2025). Prognostic Implications of Thrombocytopenia in Chinese Patients With Newly Diagnosed Multiple Myeloma. Cancer Medicine. https://doi.org/10.1002/cam4.71353

Vancouver

Li X, Lai X, Wang X, Liu Q, Liu X, Wang L, et al. Prognostic Implications of Thrombocytopenia in Chinese Patients With Newly Diagnosed Multiple Myeloma. Cancer Medicine. 2025. doi:10.1002/cam4.71353

BibTeX
@article{Li2025,
  author = {Li, Xiaojing and Lai, Xiaohui and Wang, Xiaolin and Liu, Qiang and Liu, Xin and Wang, Luqun and Peng, Jun and Chen, Ping and Zhou, Hai},
  title = {Prognostic Implications of Thrombocytopenia in Chinese Patients With Newly Diagnosed Multiple Myeloma},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71353}
}
Kostenlos starten →